Several previously published reports in the literature have demonstrated that many chemotherapeutic drugs, including 5-FU and DXR, upregulate DR5 expression on tumor cell lines of distinct tissue origin [36]–[42]. This evidence concerns the gene TNFRSF10B and neoplasm.